Two renowned research companies – one focused on preclinical research and discovery, the other on tailored microbiomic analysis – team up in order to help uncover the microbiomic components of diabetes, obesity and NAFLD/NASH
Clinical-Microbiomics is proud to announce the publication of the largest gene expression study of the human gut microbiome to date.
|Wednesday 14 September 2016 - Thursday 15 September 2016|
|Monday 03 October 2016 - Tuesday 04 October 2016|
|Wednesday 09 November 2016 - Friday 11 November 2016|